Category Disability
Blinded by the Promise of Stem Cell Treatments
Alan F. Cruess cautions against the use of unproven stem cell ‘treatments.’
Gene Therapy: A Threat to the Deaf Community?
Teresa Blankmeyer Burke considers the problematic nature of gene therapy research aimed at eliminating hereditary deafness.
Human germline genome editing: An ‘impressive’ sleight of hand?
Françoise Baylis wonders how it is that in 14 months (from December 2015 to February 2017), the U.S. National Academy of Sciences and the U.S. National Academy of Medicine have moved human germline genome editing out of the category ‘irresponsible’ and into the category ‘permissible.’
Lupron: Déjà Vu All Over Again
Alice Dreger raises concerns about a pervasive pattern of non-evidence based assumptions driving practices in pediatric endocrinology.
IVF, Multiples, and Risk: Buyer Beware
Janet Farrell Leontiou reflects on her experience as an IVF patient who was misled into choosing several multiple embryo transfers.
Limits on Medical Marijuana for Veterans
Chelsea Cox questions the federal government’s recent decision to limit reimbursement for the cost of medical marijuana used by veterans to three grams a day.
SickKids’ New Ad Campaign: Fighting words?
Michael Orsini and Anne McGuire offer a critical disability studies perspective on the Hospital for Sick Children’s latest ad campaign.
